New steroidal saponin from Antigonon leptopus Hook. and Arn.
Maria Karmella L Apaya, Christine L Chichioco-Hernandez
Institute of Chemistry, College of Science, University of the Philippines, Diliman, Quezon City 1101, Philippines
|Date of Submission||12-Oct-2014|
|Date of Acceptance||06-Dec-2014|
|Date of Web Publication||30-Aug-2014|
Christine L Chichioco-Hernandez
Institute of Chemistry, College of Science, University of the Philippines, Diliman, Quezon City 1101
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Antigonon leptopus Hook. and Arn., Polygonaceae (cadena de amor), is a herbal remedy for pain and gout-like symptoms in the Philippines. The methanol extract of A. leptopus have shown strong inhibitory action against xanthine oxidase. Objective: To isolate and identify the compound responsible for the xanthine oxidase inhibitory action. Materials and Methods: A bioassay-guided isolation scheme using an in vitro assay for the inhibition of xanthine oxidase was employed. The structure was established using spectroscopic analysis and chemical methods. Results: The isolated compound was determined to be a noncompetitive inhibitor of xanthine with an IC50 of 1.79 μg/mL. Conclusion: The isolated compound may represent a new class of xanthine oxidase inhibitors.
Keywords: Gout, medicinal plants, saponin, uric acid, xanthine oxidase
|How to cite this article:|
Apaya ML, Chichioco-Hernandez CL. New steroidal saponin from Antigonon leptopus Hook. and Arn.. Phcog Mag 2014;10, Suppl S3:501-5
|How to cite this URL:|
Apaya ML, Chichioco-Hernandez CL. New steroidal saponin from Antigonon leptopus Hook. and Arn.. Phcog Mag [serial online] 2014 [cited 2022 Jan 20];10, Suppl S3:501-5. Available from: http://www.phcog.com/text.asp?2014/10/39/501/139781
| Introduction|| |
Antigonon leptopus Hook. and Arn. is a woody, perennial member of the buckwheat (Polygonaceae) family commonly found in tropical Asia, Africa, the Caribbean and the Americas. Its common names include cadena de amor, flores kadena, bride's tears, chain-of-love and confederate vine. It is propagated by seeds or cuttings and is mostly used as an ornament. The bark, fruit, leaves, and seeds of this plant also have widespread applications in folkloric medicine. In the Philippines, the aerial parts of the plant are used as an anti-inflammatory agent and for wound healing. , In Trinidad and Tobago, the leaves are used for diabetes, urinary problems and low blood pressure.  Preliminary studies on the activity of crude extracts of A. leptopus in inhibiting the action of xanthine oxidase (XO) had been done. Results of phytochemical profiling included cardiac glycosides, steroids, tanins and terpenoids among possible types of compound responsible for this bioactivity.  Being a traditional medication used for inflammation and pain, these compounds may potentially find application as new XO inhibitors.
The only commercially available XO inhibitor to date is allopurinol (1,5-dihydro-4H-pyrazolo [3,4-d] pyrimidin-4-one), a purine analog in clinical use for >30 years.  Despite generally acceptable efficacy and safety profiles, very rare but serious adverse reactions of allopurinol administration occur including interstitial nephritis, renal failure, hepatotoxicity, vasculitis, and an array of skin rashes varying from mild to very severe and life-threatening allopurinol hypersensitivity syndrome. , The recurrence and severity of gout has been reportedly increasing over the last decades and it continues to be a major health problem due to shifts in diets and lifestyles. 
As part of our effort to search for new biologically active compounds from local herbal remedies, a new saponin, with a steroidal backbone was isolated from A. leptopus. In this paper, we present the result of the isolation, structure elucidation and XO inhibitory activity of this new compound.
| Materials and Methods|| |
Materials and instruments
Absorbance measurements were done using Thermo Scientific Multiskan Go ® . Shimadzu LC-10 high performance liquid chromatography (HPLC) system with ultraviolet (UV)-visible detector and Phenomenex semi-prep reverse phase column (00G-4461-E0) were used in HPLC analyses. Infrared spectra were obtained using a Shimadzu Fourier transform infrared (FTIR) Prestige ® while melting point was determined using Fischer-Johns melting point apparatus. Mass spectral data were obtained using 5800 AB-SCIEX matrix assisted laser desorption ionization-collision induced dissociation-time-of-flight (MALDI-CID-TOF/TOF). 1 H, 13 C and two-dimensional-NMR data were obtained using a Bruker Avance III 600 Ultrashield Plus (600 MHz). All reagents used were purchased and used as per instruction regarding handling and storage, including distilled technical grade methanol (MeOH), ethyl acetate (EtOAc) and hexane (Hex) used for crude extraction, XO from bovine milk (Sigma X4500), xanthine (Sigma X7375), allopurinol (Sigma A8003), KH 2 PO 4 (Sigma P3786), Na 2 HPO 4 (Sigma S7907) and DMSO (Sigma D1435) for the inhibitory assay, LH-20 (Sephadex), silica gel (Merck, 45 um mesh), analytical grade MeOH (JT Baker), HPLC grade acetonitrile (ACN) (JT Baker) and HPLC grade water (H 2 O) (JT baker) for isolation and purification.
Antigonon leptopus leaves were collected from various sites around the University of the Philippines-Diliman campus from the period of June 2010 to June 2011. Representative plant samples were submitted to the Institute of Biology Herbarium for proper identification and authentication. Existing voucher specimen 1809 was matched to the collected samples.
Mature leaves of A. leptopus were selected and washed with running tap water. Samples were air-dried atop acid-free paper for 3 days. The dried samples were weighed and homogenized prior to exhaustive extraction with distilled technical grade MeOH. The extracts were filtered and concentrated in vacuo yielding the crude methanolic extract. The methanolic extract was partitioned between hexane and distilled deionized water (6:1). Solvent partitioning was repeated until an almost colorless hexane layer was collected and concentrated in vacuo. Subsequent extraction of the aqueous layer with EtOAc (6:1) was done and repeated until an almost colorless organic layer was collected. The aqueous extract was freeze dried.
Column chromatography of bioactive fractions
An enzyme-guided isolation and purification scheme was used to isolate the active compounds and was done as follows: The dry weight of the active fraction was recorded and a minimum amount of MeOH was added and mixed thoroughly until homogenous prior to loading over the prepared column. A total of 2 g of aqueous extracts was used per run.
A total of 50 g of Sephadex LH-20 was swelled in analytical grade MeOH for 24 h prior to loading (2 g). A glass column with diameter of 3 cm was packed up to a height of 60 cm. Isocratic elution with MeOH was performed. Eluates were collected per 5 mL volume in 20 mL scintillation vials. Column was regenerated by thoroughly washing with MeOH after elution of each batch of extracts. Eluates were dried in vacuo using a Senti-Vac™ system. UV-visible profiles of all eluates were determined from 200 to 700 nm using MeOH as solvent. Fractions with similar profiles and maximum absorption were pooled.
Isolates were further purified using reversed phase HPLC (RP-HPLC), gradient elution with H 2 O and ACN. Fractions with the same retention times were collected. Peaks at 5, 20, 34 and 43 min were collected and pooled. Optimized parameters are as follows: λAbs = 254 nm; total flow rate: 2 mL/min; gradient: 0.01 min = 5% ACN, 5.01 min = 5% ACN, 11.01 min = 11% ACN, 60.01 min = 50% ACN, 75.01 min = 100% ACN, 80.01 min = 5% ACN, 85.01 min = 5% can.
Uncorrected melting point was determined. For FTIR analyses, samples were prepared by spread-plate technique using KBr plates. UV-visible spectra and maximum absorption of all fractions were obtained by dissolving in MeOH and recording absorbance from 200 to 700 nm. Mass spectra were obtained using a MALDI-CID-TOF/TOF machine operated with laser intensity set at 4100-4300, using 2,5-dihydroxybenzoic acid as matrix.
1 H and 13 C-NMR, distortion less enhancement by polarization transfer (DEPT), hetero nuclear multiple quantum correlation (HMQC), heteronuclear multiple-bond correlation spectroscopy (HMBC), double quantum filtered-correlated spectroscopy (DFQ-COSY), total correlation spectroscopy (TOCSY), and nuclear over hauser effect spectroscopy (NOESY) were all obtained using a 600 MHz NMR with D 2 O as solvent. NMR spectra were analyzed using MestReNova 7 by Mestrelab Research
Compound AF0501, C 38 H 62 O 14 . White amorphous powder, soluble in water. RP-HPLC retention time: 43. 1 min MP: 168°C. IR: ~3600-3000/cm (broad strong), 2900-2800/cm, 1300.00/cm, 1700 (strong)/cm. MALDI-CID-TOF/TOF: m/z 743.6430. 1 H NMR (600 MHz, D 2 O): δ 4.14 (dd, J = 7.7, 6.3 Hz, 1H), 4.07 (dt, J = 4.9, 2.6 Hz, 1H), 4.00 (m, 1H), 3.99 (m, 1H), 3.91 (m, 1H), 3.85 (bd, 1H), 3.76 (dt, J = 4.7, 2.7 Hz, 1H), 3.68 (dd, J = 12.86, 3.23 Hz, 1H), 3.66 (dd, J = 9.8, 4 Hz, 1H), 3.60 (dd, J = 7.3, 3.2 Hz, 1H), 3.53 (dd, J = 4.5.3, 2.3 Hz, 3H), 3.29 (s, 1H), 3.27 (d, J = 3.2 Hz overlap, 1H), 3.06 (td, J = 13.51, 13.43, 3.20 Hz, 1H), 2.52 (dd, J = 13.31, 3.2 Hz, 2H), 2.35 (m, 1H), 2.26 (dd, J = 13.5, 2.3 Hz, 1H), 2.24 (d, J = 7.5 Hz, 1H), 2.17 (ddd, J = 13.67, 4.80, 2.55 Hz, 3H), 2.11 (m, 2H), 2.00 (m, 2H), 1.95 (m, 1H), 1.68-1.65 (m, 7H), 1.50-1.35 (m, 3H), 1.34 (d, J = 6.8 Hz, 2H), 1.29 (t, J = 7.3 Hz, 1H), 1.05 (d, J = 6.99, 6H), 1.00 (d, J = 7.0 Hz, 3H).
13 C NMR (151 MHz, D 2 O) δ 173.37, 136.75, 124.09, 100.01, 98.69, 92.28, 80.4, 76.1, 71.19, 67.39, 67.37, 67.35, 66.97, 65.51, 62.44, 62.37, 59.41, 58.98, 57.84, 46.02, 43.61, 41.4, 39.25, 38.71, 35.84, 34.67, 32.72, 29.89, 29.03, 28.93, 26.47, 23.54, 22.53, 21.77, 20, 17.9, 16.57.
Xanthine oxidase inhibition assay
The XO inhibitory activity was assessed spectrophotometrically using a 96-well plate reader under aerobic conditions. The assay mixture consisted of the A. leptopus extract dissolved in 1% DMSO, 0.15 M phosphate buffer at pH 7.5 and the XO enzyme solution at 0.25 U/mL. All solutions were prepared just before use. After preincubation at 25°C for 10 min, the reaction was initiated by adding 0.6 mM of xanthine dissolved in phosphate buffer. Absorption increments were monitored every 30 s for 10 min at 295 nm to monitor the rate of formation of uric acid. Allopurinol was used as a positive control and XO inhibitory activity was expressed as percentage inhibition.
| Result and Discussion|| |
The pure compound was obtained as white amorphous powder with λmax at 220 nm, characteristic of an isolated C = C bond. Uncorrected melting point was determined to be 168°C. The infrared spectrum was obtained and observed peaks were assigned to corresponding functional groups. Molecular formula was determined to be C 38 H 62 O 14 (m/z 743.6430, [M + H] + ) by positive ion MALDI-CID-TOF/TOF. Fragmentation pattern showed major peaks at 663.6703, 602.3524, 522.3897, 442.4178 (base peak), 303.1420 and 221.1722.
Direct correlations ( 1 J) were established using HMQC. Related spin systems and long range homonuclear bond correlations were established using data extracted from DFQ-COSY ( 2 J- 5 J) and TOCSY ( 2 J- 5 J) spectra. Heteronuclear (C-H) correlations, from 2 J to 5 J, were verified using HMBC. Spatial correlations were established using data from the NOESY spectrum.
The 13 C-NMR spectrum gave 37 carbon signals and analysis of the DEPT spectra (DEPT 90 and DEPT 135) showed three quaternary carbons, twenty-two methines, four methyl and eight methylene carbons. Signal at C 173.37 indicates an acyl carbon with olefinic carbons at C 136.75 and C 124.09 . Several carbon atoms connected to oxygen(s) were observed with chemical shifts ranging between 60 ppm and 100 ppm. The presence of the two methyl groups at C 17.9 and six hydrogens at around 1.05-1.00 ppm, supported by the two-dimensional-NMR correlations, suggested that the isolated compound indeed has 38 carbons.
The 1 H NMR displayed two anomeric signals at H 4.14 and H 4.07 with corresponding carbons at C 100.01 and C 98.67 , respectively. These, together with the 1 H shifts connected to carbons between 60 and 100 ppm suggests that the compound has two sugar moieties. The monosaccharide units were identified as rhamnopyranose by correlations derived from TOCSY to COSY correlations and was further supported by the presence of the methyl groups as doublets at C 17.9 -H 1.05 (J = 6.99 Hz). Comparison with reported literature values ,,,,, and the data obtained from the 1 H NMR coupling constant for the anomeric proton between 4 and 8 Hz are consistent with the β-configuration for L-rhamnose. ,,,, In contrast, the coupling constants for the α-configuration of L-rhamnose is <3.0 Hz. ,,, Hence, the rhamnopyranoside units of the isolated compound were determined to be in β-configuration.
Glycosidic linkage to the corresponding two rhamnopyranosyl moieties was established at C 65.57 and is esterified at C 173.37 . For the first spin system, HMBC correlations observed between C 173.37 and H 4.01 ( 3 J) and H 2.0 ( 4 J) confirming the connectivities. For the aglycone backbone, extensive, and long range H-H correlations were identified based from TOCSY and the key HMBC correlations are as follows: H 1.0 -C 34.67 ( 3 J), H 1.0 -C 59.41 ( 4 J), H 1.34 -C 59.41 ( 3 J), H 1.29- C 34.67 ( 3 J), H 3.29 -C 38.71 ( 3 J), H 1.62 -C 62.37 ( 3 J), H 1.62 -C 41.4 ( 4 J) and H 1.68 -C 57.84 ( 3 J). [Figure 2] summarizes the key correlations. It was identified to be steroidal in nature as established by the core seventeen carbon-unit backbone (cyclopentanoperhydrophenanthrene). The β-configuration of the rhamnoside moieties were verified based from absence of NOESY correlation between H 3.53 and neighboring H's at 3.99 and 3.66 ppm for rhamnopyranose connected at C 65.57 and H 4.0 and H's at 3.66 and 3.76 ppm for rhamnopyranose connected at C 173.37 . For the aglycone, NOESY correlations between H 1.0 -H 1.29 , H 1.62 -H 2.35 -H 2.24 and H 3.27 -H 3.68 verify the structure. Furthermore, fragments corresponding to the monoisotopic peaks derived from mass spectral data support the fragmentation of this structure. The base peak, m/z 442.4178, corresponds to the monoisotopic peak of the aglycone. The structure of the steroidal saponin is shown in [Figure 1].
|Figure 1: Structure of new steroidal saponin with xanthine oxidase inhibitory activity isolated from Antigonon leptopus|
Click here to view
|Figure 2: Key correlations for the structure elucidation of the new compound|
Click here to view
Saponins and related triterpenoids and steroids had been the focus of recent studies due to their potential efficacies. They had been widely used in many countries as traditional medicine. The most popular class of these compounds is the ginsenosides mainly found in Panax ginseng. Used in traditional Asian medicine, many studies had focused on the isolation, structure elucidation and bioactivity of ginsenosides. Most notably studied are the activities of ginsenosides as antioxidants and as sources of anti-cancer compounds. 
The inhibitory activities of the crude MeOH, EtOAc, hexane and aqueous extracts of A. leptopus were determined. It has been reported previously that extracts having >50% enzyme inhibition at 50 μg/mL warranted further investigation.  Of the four, the aqueous extract inhibited XO at this level as demonstrated by a percent inhibition of 52.19% at 33.3 μg/mL. A significant loss of inhibitory activity was observed after solvent partitioning of the methanolic extract with EtOAc and Hex with percent inhibitions at 21.86% and 22.41%, respectively at 33.3 μg/mL. Inhibitory activities of fractions further purified by column chromatography using Sephadex LH-20 were determined. Results show that the activity of the pure compound is 77.45% at the same concentration with IC 50 at 1.79 μg/mL. For comparison purposes, the IC 50 value of allopurinol under the same experimental conditions was 1.00 μg/mL.
The calculated experimental K i is 2.53 ± 0.001 μM. The values of V max , on the other hand, decrease with increasing concentration of AF0501. Experiemental values are indicative of a noncompetitive type of inhibition. The experimental K i value for the pure compound is comparable to those obtained by other authors who performed similar experiments on possible noncompetitive inhibitors of xanthine oxidase.  This value is lower than the previously studied noncompetitive XO inhibitors, 2-alpha-bromo-benzimidazole (K i = 46 μM) and 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purinethiol (APT) at 5.78 μM and 6.61 μM, respectively.  Since K i is indicative of affinity of the inhibitor to the enzyme, a lower Ki value potentially means that AF0501 may inhibit XO more effectively. Furthermore, since the IC 50 of AF0501 is comparable to that of allopurinol, the isolated compound may represent a new class of XO inhibitors.
| Acknowledgments|| |
We are grateful to the Department of Science and Technology -National Research Council of the Philippines for funding this work, Dr. Andrea Jocsing, Dr. Rofe Obena and Dr. Medel Zulueta for the NMR and MS spectra.
| References|| |
|1.||Quisumbing E. Medicinal Plants of the Philippines. Quezon City, Philippines: Katha Publishing Incorporated; 1978. p. 90. |
|2.||Wester J. The use of medicinal plants by Ifugao-migrants in the foothills of the Sierra Madre mountain range. van der Ploeg J, Persoon GA, Masipiqueña MD, editors. Ifugao Migrants in and Around the Northern Sierra Madre Natural Park. CML Student Report No. 225. Leiden; 2007. Available form: http://www.pine-and-sea.com/pine_articles/20081015213725The_use_of_medicinal_plants.pdf [Last accessed on 2013 Sep 25]. |
|3.||Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed 2006;2:45. |
|4.||Chichioco-Hernandez C, Apaya K. Xanthine oxidase inhibition of selected Philippine medicinal plants. J Med Plants Res 2011;5:289-92. |
|5.||Rundles RW, Wyngaarden JB, Hitchings GH, Elion GB, Silberman HR. Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans Assoc Am Physicians 1963;76:126-40. |
|6.||Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: A review. Ann Pharmacother 1993;27:337-43. |
|7.||Sauve C, Pinquier JL, Boissonnad A, Sicard D, Christoforov B. Systemic allopurinol toxicity. Eur J Intern Med 1992;3:78-81. |
|8.||Havlik J, Gonzalez de la Huebra R, Hejtmankova K, Fernandez J, Simonova J, Melich M, et0 al. Xanthine oxidase inhibitory properties of Czech medicinal plants. J Ethnopharmacol 2010;132:461-5. |
|9.||Deng J, Liao Z, Chen D. Marsdenosides A-H, polyoxypregnane glycosides from Marsdenia tenacissima. Phytochemistry 2005;66:1040-51. |
|10.||Escobedo-Martínez C, Cruz-Morales S, Fragoso-Serrano M, Rahman MM, Gibbons S, Pereda-Miranda R. Characterization of a xylose containing oligosaccharide, an inhibitor of multidrug resistance in Staphylococcus aureus, from Ipomoea pes-caprae. Phytochemistry 2010;71:1796-801. |
|11.||Eskander J, Lavaud C, Harakat D. Steroidal saponins from the leaves of Agave macroacantha. Fitoterapia 2010;81:371-4. |
|12.||Horo I, Bedir E, Perrone A, Ozgökçe F, Piacente S, Alankuş-Calişkan O. Triterpene glycosides from Astragalus icmadophilus. Phytochemistry 2010;71:956-63. |
|13.||Phan MG, Truong TT, Phan TS, Matsunami K, Otsuka H. Three new dammarane glycosides from Betula alnoides. Phytochem Lett 2011;4:179-82. |
|14.||Pretsch E, Bühlmann P, Badertscher M, Structure Determination of Organic Compounds-Table of Spectra. New York: Springer; 2009. |
|15.||Chaturvedula VS, Upreti M, Prakash I. Structures of the novel α-glucosyl linked diterpene glycosides from Stevia rebaudiana. Carbohydr Res 2011;346:2034-8. |
|16.||Kamel MS, Assaf MH, Hasanean HA, Ohtani K, Kasai R, Yamasaki K. Monoterpene glucosides from Origanum syriacum. Phytochemistry 2001;58:1149-52. |
|17.||Park EJ, Kong Y, Lee JS, Lee SH, Lee J. Exploration of SAR regarding glucose moiety in novel C-aryl glucoside inhibitors of SGLT2. Bioorg Med Chem Lett 2011;21:742-6. |
|18.||Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI. Antioxidant polyphenols from tart cherries (Prunus cerasus). J Agric Food Chem 1999;47:840-4. |
|19.||Leung KW, Wong AS. Pharmacology of ginsenosides: A literature review. Chin Med 2010;5:20. |
|20.||Sweeney AP, Wyllie SG, Shalliker RA, Markham JL. Xanthine oxidase inhibitory activity of selected Australian native plants. J Ethnopharmacol 2001;75:273-7. |
|21.||Kalra S, Jena G, Tikoo K, Mukhopadhyay AK. Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol. BMC Biochem 2007;8:8. |
[Figure 1], [Figure 2]